Abstract:Glycolipid metabolism disorders (GLMDs) have been reported to be involved in dysfunctions of a few key enzymes such as ATP-citrate lyase (ACL) and death-associated protein kinase (DAPK)-related apoptosis inducing protein kinase-2 (DRAK2). Exploring new and effective small molecule ligands for these enzymes, natural products are expected to have the advantage over synthesized compounds. In our preceding work, a number of C50 terpenoids with bioactivities against ACL have been found from Pseudotsuga forrestii (a ‘vulnerable’ Yunnan Douglas fir) by the guidance of an LC-MS/MS-based molecular ion networking strategy. The combination of the rest portions of the EtOAc fraction from this precious plant sample did not predict any C50 compounds, but it was detected to be rich in C40/C30/C20 terpenoids and preliminarily exhibited DRAK2 inhibition. In this follow-up study, ten undescribed terpenoids (1−10) and 25 structurally related known compounds were further isolated and characterized. The new structures and their absolute configurations were determined by spectroscopic methods and/or X-ray diffraction analyses. 7,13-Friedo-lanostanes 1 and 2 feature intriguing skeletons with an unusual α, β-unsaturated spirolactone unit formed between C-13 and C-23 via oxygen-bridge or with an 8(14→13)-abeo moiety. Triterpene-monoterpene hybrid 3 could be regarded as a unique tetraterpene formed by intermolecular [4 + 2] Diels-Alder cycloaddition between a rearranged lanostane (dienophile) and a β-myrcene (diene). Methyl 15-methoxy-8,11,13-abietatrien-18-yl-succinate (9) and 3-oxo-24(E)-lanosta-8,24-dien-26-oic acid (35) were confirmed to have DRAK2 inhibitory effects with IC50 values of 6.6 and 4.1 μM, respectively. A molecular docking study disclosed alternative H-bonds/interacting amino acid residues between compounds 9/35 and the DRAK2 enzyme when comparing with those of the synthesized inhibitors reported in literature. The above findings could support the important role of protecting plant species diversity in support of chemical diversity and potential sources of new therapeutic agents for the treatment of GLMDS.

Terpenoids from Two Dicranopteris Species

Tetranorclerodanes and Clerodane-Type Diterpene Glycosides from Dicranopteris Dichotoma.

Triterpenoid Saponins from Dianthus Versicolor.

Anti-Inflammatory Terpenoids From The Leaves And Twigs Of Dysoxylum Gotadhora

Kadcoccinic Acids A-J, Triterpene Acids from Kadsura Coccinea.

Ent-Kaurane Diterpenoids from Isodon Albopilosus.

Kadcotriones A-C: Tricyclic Triterpenoids from Kadsura Coccinea.

Terpenoids and hexenes from the leaves of Crataegus pinnatifida

A New Triterpenoid From Teucrium Viscidum

Diverse Types of Diterpenoids with an Aromatized C Ring from the Twigs of Podocarpus imbricatus

New tocopherol and acylphloroglucinol derivatives from Dryopteris crassirhizoma and their antimicrobial activities

Two New Terpenoids from Talaromyces purpurogenus

Diterpenoids caryopterisoids D - Q and iridoid glucoside derivatives caryopterisides F - H from Caryopteris glutinosa

Terpenoids and Norlignans from Metasequoia Glyptostroboides

Terpenoids from <i>Penicillium chrysogenum</i> MT-40, an endophytic fungus isolated from <i>Huperzia serrata</i>

Structurally Diverse Secondary Metabolites from a Deep-Sea Derived Cladosporium sp. SCSIO 41318and Their Biological Evaluation

Sesquiterpenoids from the Mangrove-Derived Endophytic Fungus Diaporthe Sp.

Structurally Diverse Terpenoids and Their DRAK2 Inhibitory Activities: A Follow-Up Study on the Vulnerable Conifer Pseudotsuga Forrestii

Sesquiterpenes from the secondary metabolites of Streptomyces sp. (YIM 56130)

Antimicrobial Acylphloroglucinol Meroterpenoids and Acylphloroglucinols from Dryopteris crassirhizoma

Terpenes isolated from Polyalthia simiarum and their cytotoxic activities